These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18024395)

  • 21. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
    Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B
    J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome.
    Claudino M; Trombone AP; Cardoso CR; Ferreira SB; Martins W; Assis GF; Santos CF; Trevilatto PC; Campanelli AP; Silva JS; Garlet GP
    J Leukoc Biol; 2008 Dec; 84(6):1565-73. PubMed ID: 18725394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
    Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
    Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
    Li G; Li D
    Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
    Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
    Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
    Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
    Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distribution of single nucleotide polymorphisms of IL-10 gene in patients with mucoviscidosis].
    Kashyn OI; Zastavna DV; Makykh HV
    Tsitol Genet; 2006; 40(3):40-4. PubMed ID: 16933851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
    Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
    Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
    Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
    Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
    Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
    J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
    Kube D; Hua TD; Klöss M; Kulle B; Brockmöller J; Wojnowski L; Löffler M; Pfreundschuh M; Trümper L
    Genes Immun; 2007 Mar; 8(2):164-7. PubMed ID: 17215862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease.
    Amre DK; Mack DR; Morgan K; Israel D; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Deslandres C; Levy E; Seidman EG
    Aliment Pharmacol Ther; 2009 May; 29(9):1025-31. PubMed ID: 19210299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
    Singh H; Sachan R; Goel H; Mittal B
    BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.